Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Enzotime Pro
- Development stage
- Preclinical
- Lead developer
- Intra Life
- Modality
- Live Biotherapeutic Products → Microbiome Therapeutics, Recombinant Proteins and Enzymes
- Administration
- Oral
01
Overview
Enzotime Pro is an oral dietary supplement developed by Intra Life to support digestive and gut health. It is formulated as a capsule containing DigeZyme, a proprietary multi-enzyme complex consisting of amylase, protease, cellulase, lactase, and lipase, combined with the probiotic strain LactoSpore (Bacillus coagulans SNZ-1969). The formulation is further enriched with riboflavin-5-phosphate, magnesium, and potassium. Enzotime Pro is designed to assist in the breakdown of carbohydrates, proteins, cellulose, lactose, and lipids, while promoting a healthy intestinal microbiome and relieving symptoms of indigestion, dyspepsia, bloating, and gas.
- Brand names
- Enzotime Pro
Beyond the preview
Go deeper on Enzotime Pro.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Enzotime Pro.